Verona Pharma plc VRNA | $60.52M | 37.11 | 3.76M | -2.71% | -$1.68M | 0.04 | |
Lyra Therapeutics, Inc. LYRA | $79.35M | 20.93 | 12.76M | 0% | +$0 | 0.05 | |
Solid Biosciences Inc. SLDB | $92M | 18 | 6.91M | +97.56% | +$45.43M | 0.06 | |
MeiraGTx Holdings plc MGTX | $68.72M | 17.62 | 11.33M | 0% | +$0 | 0.05 | |
Verrica Pharmaceuticals Inc. VRCA | $42.03M | 16.74 | 7.1M | 0% | +$0 | 0.03 | |
Astria Therapeutics, Inc. ATXS | $91.25M | 11.81 | 6.49M | +61.97% | +$34.91M | 0.06 | |
Nautilus Biotechnology, Inc. NAUT | $37.03M | 10.05 | 12.59M | 0% | +$0 | 0.02 | |
Amicus Therapeutics, Inc. FOLD | $330.52M | 9.47 | 28.06M | 0% | +$0 | 0.21 | |
Evolus, Inc. EOLS | $80.55M | 9.19 | 5.75M | +45.17% | +$25.07M | 0.05 | |
Soleno Therapeutics, Inc. SLNO | $131.59M | 8.87 | 3.07M | 0% | +$0 | 0.09 | |
CARGO Therapeutics, Inc. Common Stock CRGX | $76.96M | 8.76 | 3.45M | +0.33% | +$254,537.28 | 0.05 | |
Fusion Pharmaceuticals Inc. FUSN | $145.52M | 8.02 | 6.83M | +148.07% | +$86.86M | 0.09 | |
Celcuity Inc. CELC | $51.03M | 7.56 | 2.36M | +59.47% | +$19.03M | 0.03 | |
Arcellx, Inc. ACLX | $273.58M | 7.35 | 3.93M | -13.45% | -$42.51M | 0.18 | |
Applied Therapeutics, Inc. APLT | $54.43M | 7.01 | 8.01M | +96.19% | +$26.69M | 0.04 | |
Iovance Biotherapeutics, Inc. IOVA | $285.63M | 6.89 | 19.27M | +60.88% | +$108.09M | 0.19 | |
Artivion, Inc. AORT | $56.48M | 6.4 | 2.67M | +186.57% | +$36.77M | 0.04 | |
Spyre Therapeutics, Inc. SYRE | $96.97M | 6.35 | 2.56M | -1.92% | -$1.9M | 0.06 | |
Cerevel Therapeutics Holdings, Inc. CERE | $456.3M | 5.93 | 10.79M | -1.55% | -$7.2M | 0.3 | |
Viridian Therapeutics, Inc. VRDN | $64.04M | 5.73 | 3.66M | +111.37% | +$33.74M | 0.04 | |
Rhythm Pharmaceuticals, Inc. RYTM | $141.63M | 5.36 | 3.27M | +51.74% | +$48.29M | 0.09 | |
Praxis Precision Medicines, Inc. PRAX | $50.13M | 4.8 | 821,589 | New | +$50.13M | 0.03 | |
Apogee Therapeutics, Inc. APGE | $179.37M | 4.62 | 2.7M | +47.67% | +$57.91M | 0.12 | |
Immatics N.V. IMTX | $48.16M | 4.45 | 4.58M | +31.25% | +$11.47M | 0.03 | |
Nuvalent, Inc. NUVL | $209.01M | 4.31 | 2.78M | -4.61% | -$10.1M | 0.14 | |
Disc Medicine, Inc. IRON | $58.52M | 3.8 | 939,866 | -8.13% | -$5.18M | 0.04 | |
Tarsus Pharmaceuticals, Inc. TARS | $47.12M | 3.43 | 1.3M | 0% | +$0 | 0.03 | |
SpringWorks Therapeutics, Inc. SWTX | $111.36M | 3.05 | 2.26M | +15.59% | +$15.02M | 0.07 | |
ADMA Biologics, Inc. ADMA | $42.46M | 2.78 | 6.43M | 0% | +$0 | 0.03 | |
Edgewise Therapeutics, Inc. EWTX | $42.31M | 2.48 | 2.32M | +317.54% | +$32.18M | 0.03 | |
Axsome Therapeutics, Inc. AXSM | $88.21M | 2.33 | 1.11M | +6.49% | +$5.37M | 0.06 | |
Immunovant, Inc. IMVT | $95.74M | 2.03 | 2.96M | +27.28% | +$20.52M | 0.06 | |
Madrigal Pharmaceuticals, Inc. MDGL | $114.81M | 2.02 | 429,953 | +184.45% | +$74.45M | 0.07 | |
Akero Therapeutics, Inc. AKRO | $35.05M | 2.01 | 1.39M | +43.37% | +$10.6M | 0.02 | |
Rocket Pharmaceuticals, Inc. RCKT | $48.52M | 1.98 | 1.8M | +5.49% | +$2.52M | 0.03 | |
CG Oncology, Inc. Common stock CGON | $57.25M | 1.96 | 1.3M | New | +$57.25M | 0.04 | |
Biohaven Pharmaceutical Holding Company Ltd. BHVN | $94.34M | 1.95 | 1.73M | 0% | +$0 | 0.06 | |
Crinetics Pharmaceuticals, Inc. CRNX | $69.1M | 1.87 | 1.48M | +17.58% | +$10.33M | 0.05 | |
Arvinas, Inc. ARVN | $51.05M | 1.81 | 1.24M | +249.24% | +$36.43M | 0.03 | |
Vaxcyte, Inc. PCVX | $132.03M | 1.78 | 1.93M | +77.56% | +$57.67M | 0.09 | |
Xenon Pharmaceuticals Inc. XENE | $38.41M | 1.18 | 892,208 | -18.95% | -$8.98M | 0.03 | |
Intra-Cellular Therapies, Inc. ITCI | $73.03M | 1 | 1.06M | +877.18% | +$65.56M | 0.05 | |
Viking Therapeutics, Inc. VKTX | $81.52M | 0.9 | 994,098 | New | +$81.52M | 0.05 | |
Neurocrine Biosciences, Inc. NBIX | $110.94M | 0.8 | 804,409 | +197.06% | +$73.6M | 0.07 | |
BridgeBio Pharma, Inc. BBIO | $43.66M | 0.76 | 1.41M | -19.26% | -$10.42M | 0.03 | |
Natera, Inc. NTRA | $69.26M | 0.62 | 757,225 | -10.94% | -$8.51M | 0.05 | |
Sarepta Therapeutics, Inc. SRPT | $68.05M | 0.56 | 525,683 | +16.33% | +$9.56M | 0.04 | |
Medtronic plc MDT | $124.59M | 0.11 | 1.43M | +46.37% | +$39.47M | 0.08 | |
Intuitive Surgical, Inc. ISRG | $40.63M | 0.03 | 101,800 | +85.09% | +$18.68M | 0.03 | |
Inhibrx, Inc. INBX | $148.79B | <0.01 | 4.26M | 0% | +$0 | 96.43 |